286
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence of Heavy Alcohol Use Among People Receiving Methadone Following Change to Methadose

, , , , &

References

  • Aertgeerts, B., Buntinx, F., Ansoms, S., & Fevery, J. (2002). Questionnaires are better than laboratory tests to screen for current alcohol abuse or dependence in a male inpatient population. Acta Clinica Belgica, 57(5), 241–249. doi:10.1179/acb.2002.048
  • Beverley, C. L., Kreek, M. J., Wells, A. O., & Curtis, J. L. (1979). Effects of alcohol abuse on progression of liver disease in methadone-maintained patients. NIDA Research Monographs, 27, 399–401.
  • Bickel, W. K., Marion, I., & Lowinson, J. H. (1987). The treatment of alcoholic methadone patients: A review. Journal of Substance Abuse Treatment, 4(1), 15–19.
  • Bourgois, P. (2000). Disciplining addictions: The Bio-politics of Methadone and Heroin in the United States. Culture, Medicine and Psychiatry, 24(2), 165–195. doi:10.1023/a:1005574918294
  • British Columbia Ministry of Health. (2015). Methadone maintenance payment program: Review. Retrieved May 18th, 2017 from Medical Beneficiary and Pharmaceutical Services Division: http://www.yourcaringcommunity.ca/uploads/1/2/0/0/12000964/methadone_maintenance_payment_program.pdf
  • Cohen, A., McKeever, W., Cohen, M., & Stimmel, B. (1977). The use of an alcoholism screening test to identify the potential for alcoholism in persons on methadone maintenance. American Journal of Drug and Alcohol Abuse, 4(2), 257–266.
  • CPSBC. (2014). Methadone maintenance program: Clinical practice guideline. Retrieved from https://www.cpsbc.ca/files/pdf/MMP-Clinical-Practice-Guideline-2014-02.pdf
  • Cullen, W., Kelly, Y., Stanley, J., Langton, D., & Bury, G. (2005). Experience of hepatitis C among current or former heroin users attending general practice. Irish Medical Journal, 98(3), 73–74.
  • Cushman, P., Kreek, M. J., & Gordis, E. (1978). Ethanol and methadone in man: A possible drug interaction. Drug & Alcohol Dependence, 3(1), 35–42. doi:10.1016/0376-8716(78)90033-9
  • Darke, S. (1998). Self-report among injecting drug users: a review. Drug and Alcohol Dependence, 51(3), 253–263; discussion 267–258.
  • Dole, V. P., & Nyswander, M. (1965). A medical treatment for diacetylmorphine (Heroin) addiction a clinical trial with methadone hydrochloride. JAMA: The Journal of the American Medical Association, 193(8), 646–650.
  • Doll, R., Peto, R., Hall, E., Wheatley, K., & Gray, R. (1994). Mortality in relation to consumption of alcohol: 13 sources' observations on male British doctors. BMJ: British Medical Journal, 309(6959), 911–918.
  • Farr, B. M., & Gwaltney, J. M., Jr. (1987). The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold. Journal of Chronic Diseases, 40(9), 875–879.
  • Fischer, B. (2000). Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada. Journal of Public Health Policy, 21(2), 187–210. doi:10.2307/3343343
  • Gourevitch, M. N., Hartel, D., Tenore, P., Freeman, K., Marion, I., Hecht, J., & Lowinson, J. (1999). Three oral formulations of methadone. A clinical and pharmacodynamic comparison. Journal of Substance Abuse Treatment, 17(3), 237–241.
  • Greer, A. M., Hu, S., Amlani, A., Moreheart, S., Sampson, O., & Buxton, J. A. (2016). Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey. Substance Abuse Treatment, Prevention, and Policy, 11(1), 1–8. doi:10.1186/s13011-016-0048-3
  • Hart, C. L., Davey Smith, G., Hole, D. J., & Hawthorne, V. M. (1999). Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of Scottish men with 21 sources of follow up. BMJ, 318(7200), 1725.
  • Hartman, N., Kreek, M. J., Ross, A., Khuri, E., Millman, R. B., & Rodriguez, R. (1983). Alcohol use in youthful methadone-maintained former heroin addicts: Liver impairment and treatment outcome. Alcoholism: Clinical and Experimental Research, 7(3), 316–320. doi:10.1111/j.1530-0277.1983.tb05469.x
  • Hartzler, B., Donovan, D. M., & Huang, Z. (2010). Comparison of opiate-primary treatment seekers with and without alcohol use disorder. Journal of Substance Abuse Treatment, 39(2), 114–123. doi: S0740-5472(10)00102-9 [pii], 10.1016/j.jsat.2010.05.008
  • Hayashi, K., Dong, H., Marshall, B. D. L., Milloy, M.-J., Montaner, J. S. G., Wood, E., & Kerr, T. (2016). Sex-based differences in rates, causes, and predictors of death among injection drug users in Vancouver, Canada. American Journal of Epidemiology, 183(6), 544–552. doi:10.1093/aje/kwv207
  • Johnson, C., Dong, H., Ahamad, K., Hayashi, K., Milloy, M. J., Kerr, T., & Wood, E. (2015). Impact of binge alcohol on mortality among people who inject drugs. Addictive Behaviors Reports, 2, 28–32. doi:10.1016/j.abrep.2015.05.002
  • Kaner, E. F., Beyer, F., Dickinson, H. O., Pienaar, E., Campbell, F., Schlesinger, C., … Burnand, B. (2007). Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews (2), CD004148.
  • Kerr, T., Small, W., Hyshka, E., Maher, L., & Shannon, K. (2013). ‘It's more about the heroin’: injection drug users' response to an overdose warning campaign in a Canadian setting. Addiction, 108(7), 1270–1276.
  • Kerr, T., Small, W., Johnston, C., Li, K., Montaner, J. S., & Wood, E. (2008). Characteristics of injection drug users who participate in drug dealing: implications for drug policy. Journal of Psychoactive Drugs, 40(2), 147–152.
  • Kipnis, S. S., Herron, A., Perez, J., & Joseph, H. (2001). Integrating the methadone patient in the traditional addiction inpatient rehabilitation program–problems and solutions. Mount Sinai Journal of Medicine, 68(1), 28–32.
  • Klimas, J., Dong, H., Dobrer, S., Milloy, M. J., Kerr, T., Wood, E., & Hayashi, K. (2016). Alcohol use among persons on methadone treatment. Addictive Disorders & Their Treatment, 16(1), 36–37.
  • Klimas, J., Wood, E., Nguyen, P., Dong, H., Milloy, M., Kerr, T., & Hayashi, K. (2016). The impact of enrolment in methadone maintenance therapy on initiation of heavy drinking among people who use heroin. European Addiction Research, 22(4), 210–214.
  • Liebson, I. A., Tommasello, A., & Bigelow, G. E. (1978). A behavioral treatment of alcoholic methadone patients. Annals of Internal Medicine, 89(3), 342–344. doi:10.1059/0003-4819-89-3-342
  • Luce, J., & Strike, C. (2011). A Cross-Canada Scan of Methadone Maintenance Treatment Policy Developments. Retrieved May 17, 2017, from the Controlled Drugs and Substances Act: http://www.ceca-cect.ca/pdf/CECA%20MMT%20Policy%20Scan%20April%202011.pdf
  • Markwick, N., McNeil, R., Anderson, S., Small, W., & Kerr, T. (2016). Communicating risk in the context of methadone formulation changes: A qualitative study of overdose warning posters in Vancouver, Canada. International Journal of Drug Policy, 27, 178–181. doi:10.1016/j.drugpo.2015.10.013
  • Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews (3), Art. No.: CD002209. doi:10.1002/14651858.CD002209.pub2
  • McNeil, R., Kerr, T., Anderson, S., Maher, L., Keewatin, C., Milloy, M. J., … Small, W. (2015). Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study. Social Science & Medicine, 133, 168–176. doi:https://doi.org/10.1016/j.socscimed.2015.04.008
  • Miller, P. G. (2007). Media reports of heroin overdose spates: Public health messages, moral panics or risk advertisements? Critical Public Health, 17(2), 113–121. doi:10.1080/09581590601045220
  • National Institute on Alcohol Abuse and alcoholism (NIAAA). (2010). Rethinking drinking: Alcohol and your health. NIH Pub No 13-370. Retrieved from http://pubs.niaaa.nih.gov/publications/RethinkingDrinking/Rethinking_Drinking.pdf
  • Nosyk, B., Sun, H., Evans, E., Marsh, D. C., Anglin, M. D., Hser, Y.-I., & Anis, A. H. (2012). Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction, 107(9), 1621–1629. doi:10.1111/j.1360-0443.2012.03870.x
  • Silver, J. S., & Shaffer, H. J. (1996). Change intolerance to shifts in methadone formulation: A preliminary investigation. Journal of Substance Abuse Treatment, 13(4), 331–339.
  • Soyka, M. (2015). Alcohol use disorders in opioid maintenance therapy: Prevalence, clinical correlates and treatment. European Addiction Research, 21(2), 78–87.
  • Soyka, M., & Zingg, C. (2009). Feasability and safety of transfer from racemic methadone to (R)-methadone in primary care: clinical results from an open study. World Journal of Biological Psychiatry, 10(3), 217–224. doi:10.1080/15622970802416057
  • Staiger, P. K., Richardson, B., Long, C., Carr, V., & Marlatt, G. A. (2013). Overlooked and underestimated? Problematic alcohol use in clients recovering from drug dependence. Addiction, 108(7), 1188–1193. doi:10.1111/j.1360-0443.2012.04075.x
  • Stimmel, B., Cohen, M., Sturiano, V., Hanbury, R., Korts, D., & Jackson, G. (1983). Is treatment for alcoholism effective in persons on methadone maintenance? American Journal of Psychiatry, 140(7), 862–866.
  • Strathdee, S. A., Palepu, A., Cornelisse, P. G., Yip, B., O'Shaughnessy, M. V., Montaner, J. S., … Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. JAMA, 280(6), 547–549.
  • Tong, T. G., Benowitz, N. L., & Kreek, M. J. (1980). Methadone—disulfiram interaction during methadone maintenance. The Journal of Clinical Pharmacology, 20(8–9), 506–513. doi:10.1002/j.1552-4604.1980.tb02543.x
  • Wood, E., Hogg, R. S., Bonner, S., Kerr, T., Li, K., Palepu, A., … Montaner, J. S. (2004). Staging for antiretroviral therapy among HIV-infected drug users. JAMA, 292(10), 1175–1177.
  • Wurst, F. M., Thon, N., Yegles, M., Halter, C., Weinmann, W., Laskowska, B., … Dursteler-Macfarland, K. (2011). Optimizing heroin-assisted treatment (HAT): Assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use. Drug Alcohol Depend, 115(1–2), 57–61. doi:10.1016/j.drugalcdep.2010.10.020
  • Young, S. V., Wood, E., Dong, H., Kerr, T., & Hayashi, K. (2016). Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs. Addiction, 111(8), 1360–1365. doi:10.1111/add.13256

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.